MELAVAC Trademark

Trademark Overview

On Friday, January 29, 2010, a trademark application was filed for MELAVAC with the United States Patent and Trademark Office. The USPTO has given the MELAVAC trademark a serial number of 77923680. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 8, 2012. This trademark is owned by Ultra Biotech Limited. The MELAVAC trademark is filed in the Pharmaceutical Products category with the following description:

Medicines for the treatment of melanoma
melavac

General Information

Serial Number77923680
Word MarkMELAVAC
Filing DateFriday, January 29, 2010
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 8, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 11, 2011

Trademark Statements

Translation of Words in MarkThe wording "MELAVAC" has no meaning in a foreign language.
Goods and ServicesMedicines for the treatment of melanoma

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 3, 2010
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameUltra Biotech Limited
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressDouglas IM11SA
IM
Party NameUltra Biotech Limited
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDouglas IM11SA
IM

Trademark Events

Event DateEvent Description
Tuesday, February 2, 2010NEW APPLICATION ENTERED
Wednesday, February 3, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, April 29, 2010ASSIGNED TO EXAMINER
Wednesday, May 5, 2010NON-FINAL ACTION WRITTEN
Wednesday, May 5, 2010NON-FINAL ACTION E-MAILED
Wednesday, May 5, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, November 4, 2010TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, November 19, 2010ASSIGNED TO LIE
Monday, November 22, 2010CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 22, 2010TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, November 24, 2010APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, December 6, 2010LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, January 11, 2011PUBLISHED FOR OPPOSITION
Tuesday, January 11, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, January 12, 2011TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 13, 2011TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, September 1, 2011SOU TEAS EXTENSION RECEIVED
Thursday, September 1, 2011SOU EXTENSION 1 FILED
Thursday, September 1, 2011SOU EXTENSION 1 GRANTED
Saturday, September 3, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 1, 2012SOU TEAS EXTENSION RECEIVED
Thursday, March 22, 2012CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, March 1, 2012SOU EXTENSION 2 FILED
Thursday, March 22, 2012SOU EXTENSION 2 GRANTED
Friday, March 23, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 8, 2012ABANDONMENT - NO USE STATEMENT FILED
Tuesday, October 9, 2012ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED

Related Keywords

melavac melanoma treatment medicines